In yesterday’s Wall Street session, HEXO Corp. (NASDAQ:HEXO) shares traded at $0.17, unchanged from the previous session.
4 analysts cover HEXO Corp. (NASDAQ:HEXO), according to research data. The consensus rating among analysts is ‘Underweight’. As we calculate the median target price by taking the range between a high of $0.22 and a low of $0.07, we find $0.17. HEXO stock price is now -6.03% away from the 50-day moving average and -46.29% away from the 200-day moving average. The market capitalization of the company currently stands at $100.66M.
The stock has received a hold rating from 3 analysts and a buy rating from 0. Brokers who have rated the stock have averaged $0.16 as their price target over the next twelve months.
On January 27, 2022, Jefferies Upgraded its previous ‘Underperform’ rating to ‘Hold’ on the stock reducing its target price from $1.07 to quote $0.53, while ‘CIBC’ rates the stock as ‘Sector Underperform’.
A total of 2.73% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in HEXO stock. A new stake in HEXO Corp. shares was purchased by BAYESIAN CAPITAL MANAGEMENT, LP during the first quarter worth $8,000. VIRTU FINANCIAL LLC invested $6,000 in shares of HEXO during the first quarter. In the first quarter, MARINER, LLC acquired a new stake in HEXO Corp. valued at approximately $4,000. GRAYPOINT LLC acquired a new stake in HEXO for approximately $2,000. In total, there are 118 active investors with 13.26% ownership of the company’s stock.
On Wednesday morning HEXO Corp. (NASDAQ: HEXO) stock kicked off with the opening price of $0.1700. During the past 12 months, HEXO Corp. has had a low of $0.17 and a high of $1.23. As of last week, the company has a debt-to-equity ratio of 0.80, a current ratio of 0.80, and a quick ratio of 0.60. The fifty day moving average price for HEXO is $0.1804 and a two-hundred day moving average price translates $0.3142 for the stock.
The latest earnings results from HEXO Corp. (NASDAQ: HEXO) was released for Apr, 2022. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.27, missing analysts’ expectations of -$0.03 by -0.24. This compares to -$0.41 EPS in the same period last year. The company reported revenue of $32.99 million for the quarter, compared to $31.36 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.18 percent. For the current quarter, analysts expect HEXO to generate $32.29M in revenue.
HEXO Corp.(HEXO) Company Profile
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.